Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Pediatrics | Roseola Infantum
May 3, 2026
9m 27s
Pediatrics | Tay-Sachs Disease
May 2, 2026
9m 27s
Pediatrics | Neonatal Abstinence Syndrome
May 1, 2026
7m 12s
Pediatrics | X-Linked Agammaglobulinemia
Apr 30, 2026
8m 04s
Oncology | Hairy Cell Leukemia (HCL)
Apr 29, 2026
7m 36s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/3/26 | Pediatrics | Roseola Infantum✨ | PediatricsRoseola Infantum+3 | — | MedbulletsRoseola Infantum | — | RoseolaPediatrics+3 | — | 9m 27s | |
| 5/2/26 | Pediatrics | Tay-Sachs Disease✨ | PediatricsTay-Sachs Disease+3 | — | MedbulletsTay-Sachs Disease | — | Tay-SachsPediatrics+3 | — | 9m 27s | |
| 5/1/26 | Pediatrics | Neonatal Abstinence Syndrome✨ | PediatricsNeonatal Abstinence Syndrome+3 | — | MedbulletsNeonatal Abstinence Syndrome | — | Neonatal Abstinence SyndromePediatrics+4 | — | 7m 12s | |
| 4/30/26 | Pediatrics | X-Linked Agammaglobulinemia✨ | PediatricsX-Linked Agammaglobulinemia+3 | — | MedbulletsX-Linked Agammaglobulinemia | — | X-Linked AgammaglobulinemiaPediatrics+3 | — | 8m 04s | |
| 4/29/26 | Oncology | Hairy Cell Leukemia (HCL)✨ | OncologyHairy Cell Leukemia+3 | — | MedbulletsHairy Cell Leukemia (HCL) | — | Hairy Cell LeukemiaHCL+3 | — | 7m 36s | |
| 4/28/26 | Oncology | Desmoid Tumors✨ | OncologyDesmoid Tumors+1 | — | MedbulletsDesmoid Tumors | — | OncologyDesmoid Tumors+3 | — | 9m 11s | |
| 4/27/26 | Oncology | Gardner Syndrome✨ | OncologyGardner Syndrome+4 | — | MedbulletsGardner Syndrome | — | Gardner SyndromeOncology+4 | — | 6m 57s | |
| 4/26/26 | Oncology | Meningioma✨ | OncologyMeningioma+3 | — | MedbulletsMeningioma | — | MeningiomaOncology+3 | — | 13m 20s | |
| 4/25/26 | Oncology | Neuroblastoma✨ | OncologyNeuroblastoma+3 | — | MedbulletsNeuroblastoma | — | NeuroblastomaOncology+3 | — | 8m 11s | |
| 4/24/26 | Oncology | Actinic Keratosis✨ | OncologyActinic Keratosis+3 | — | Medbullets | — | Actinic KeratosisOncology+3 | — | 7m 14s | |
| 4/23/26 | Oncology | Choriocarcinoma✨ | OncologyChoriocarcinoma+1 | — | MedbulletsChoriocarcinoma | — | ChoriocarcinomaOncology+3 | — | 8m 25s | |
| 4/22/26 | Neurology | Lumbar Puncture✨ | Lumbar PunctureNeurology+3 | — | Medbullets | — | Lumbar PunctureNeurology+5 | — | 10m 37s | |
| 4/21/26 | Neurology | Neuro Trauma✨ | Neuro TraumaNeurology+1 | — | Medbullets | — | Neuro TraumaNeurology+3 | — | 14m 29s | |
| 4/20/26 | Neurology | Wernicke-Korsakoff Syndrome✨ | NeurologyWernicke-Korsakoff Syndrome+3 | — | MedbulletsWernicke-Korsakoff Syndrome | — | Wernicke-Korsakoff Syndromeneurology+3 | — | 8m 46s | |
| 4/19/26 | Neurology | Toxoplasmosis (CNS)✨ | ToxoplasmosisCNS+3 | — | Medbullets | — | ToxoplasmosisCNS+3 | — | 10m 12s | |
| 4/18/26 | Neurology | Basilar Skull Fracture✨ | Basilar Skull FractureNeurology+3 | — | Medbullets | — | Basilar Skull FractureNeurology+4 | — | 16m 38s |
Showing 16 of 16
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.